A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

NCT01007435 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1162

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab
DRUG: Placebo to tocilizumab
DRUG: Methotrexate
DRUG: Placebo to methotrexate

Sponsor

Hoffmann-La Roche